ArticleOncotarget2017

Characterization of CADD522, a small molecule that inhibits RUNX2-DNA binding and exhibits antitumor activity.

Myoung Sook Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.